Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
about
Gene therapy for Wiskott-Aldrich Syndrome-Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis.Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization.Organ targeted prenatal gene therapy--how far are we?Drug target discovery using retroviruses.Recent developments in retroviral gene delivery systems.Prenatal gene therapy for the early treatment of genetic disorders
P2860
Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Targeted gene transfer to lymp ...... rosis virus envelope proteins.
@en
type
label
Targeted gene transfer to lymp ...... rosis virus envelope proteins.
@en
prefLabel
Targeted gene transfer to lymp ...... rosis virus envelope proteins.
@en
P2093
P2860
P356
P1433
P1476
Targeted gene transfer to lymp ...... rosis virus envelope proteins.
@en
P2093
Buchholz CJ
Cichutek K
Engelstädter M
Merget-Millitzer H
Willemsen RA
P2860
P2888
P304
P356
10.1038/SJ.GT.3301500
P577
2001-08-01T00:00:00Z
P5875
P6179
1033367888